ARCHIVES

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

UT Board Announces Support for MD Anderson Tenure System

October 10, 2014

FDA Approves Merck’s Gardasil Vaccine To Prevent Cervical Cancer.

June 9, 2006

NCI funds four radiation oncology cancer disparities research partnerships.

October 10, 2003

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

April 2, 1993

NCAB Hears Good News: FY 92 Budget Allows NCI To Increase Levels Of Most Programs

November 29, 1991

Congress Passes FDA User Fee Bill, Averting Layoffs.

September 21, 2007